AAP: Auvi-Q Epinephrine Injectors Recalled

American Academy of Pediatrics News

October 29, 2015


Sanofi U.S. is voluntarily recalling all Auvi-Q epinephrine auto-injectors due to suspected malfunctions that could deliver the wrong dose of medication.

The injectors are used to treat life-threatening allergic reactions, and a patient receiving an incorrect dose could face serious health consequences including death,according to an alert from the Food and Drug Administration.

Anyone experiencing adverse reactions after using Auvi-Q should contact their doctor and submit a report to the FDA at www.fda.gov/MedWatch/report or call 800-332-1088.

For instructions on returning their devices, Auvi-Q customers can contact the company at www.Auvi-Q.com, by email at cs@sanofi.com or by phone at 866-726-6340. Sanofi will reimburse customers for the out-of-pocket costs of purchasing a new auto-injector.

For the complete press release, click here.


Last updated:02-Nov-2015 10:37 AM